J2KBIO제이투케이바이오
420570 · KOSDAQ · ₩420570 · 제이투케이바이오
₩7,300▼ ₩430 (5.56%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Gross margin | 39.6% | 39.4% | 38.2% | 40.4% |
| Operating margin | 14.8% | 8.9% | 10.9% | 19.7% |
| Net margin | 13.2% | 8.1% | −5.0% | 17.0% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue growth | +33.2% | −0.5% | +16.4% | — |
| Operating income growth | +122.6% | −19.5% | −35.3% | — |
| Net income growth | +117.5% | +261.7% | −134.1% | — |
Returns
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Return on equity | 16.5% | 8.2% | −6.7% | 27.2% |
| Return on assets | 10.9% | 7.2% | −5.8% | 21.8% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Liabilities to equity | 18.7% | 12.7% | 14.7% | 23.6% |
| Net debt to equity | −24.1% | −35.1% | −18.2% | −16.4% |
| Current ratio | 411.4% | 708.9% | 788.4% | 377.5% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: J2KBIO / 제이투케이바이오 / 420570 / KRX:420570
Source: KRX statistical information